Edition:
United Kingdom

ReShape Lifesciences Inc (RSLS.OQ)

RSLS.OQ on NASDAQ Stock Exchange Capital Market

1.47USD
16 Jul 2018
Change (% chg)

-- (--)
Prev Close
$1.47
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
41,000
52-wk High
$78.00
52-wk Low
$1.33

Chart for

About

ReShape Lifesciences Inc., formerly EnteroMedics Inc., is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC... (more)

Overall

Beta: 3.09
Market Cap(Mil.): $17.00
Shares Outstanding(Mil.): 8.29
Dividend: --
Yield (%): --

Financials

  RSLS.OQ Industry Sector
P/E (TTM): -- 148.52 32.76
EPS (TTM): -16.61 -- --
ROI: -117.87 9.38 14.61
ROE: -146.36 14.71 16.34

UPDATE 1-FDA reports 5 more deaths related to intragastric balloons

June 4 The U.S. Food and Drug Administration on Monday notified healthcare providers that it had received reports of five more deaths in patients using liquid-filled intragastric balloon systems to treat obesity, bringing the total death toll to 12 since 2016.

04 Jun 2018

BRIEF-Reshape Lifesciences Files For Mixed Shelf Of Up To $125 Mln

* RESHAPE LIFESCIENCES FILES FOR MIXED SHELF OF UP TO $125 MILLION - SEC FILING Source text: (https://bit.ly/2Ljt5n1) Further company coverage:

21 May 2018

BRIEF-Reshape Lifesciences Announces Submission For Approval Of Reshape Balloon In Canada

* RESHAPE LIFESCIENCES ANNOUNCES SUBMISSION FOR APPROVAL OF RESHAPE BALLOON™ IN CANADA Source text for Eikon: Further company coverage:

10 May 2018

BRIEF-Bobby Griffin To Retire From Reshape Lifesciences' Board

* RESHAPE LIFESCIENCES - ANNOUNCED THAT BOBBY I. GRIFFIN WILL RETIRE FROM BOARD OF DIRECTORS

24 Apr 2018

BRIEF-Reshape Lifesciences Says Reshape Balloon Granted Registration By National Health Regulation Authority In Kingdom Of Bahrain

* RESHAPE LIFESCIENCES INC - RESHAPE BALLOON GRANTED REGISTRATION BY NATIONAL HEALTH REGULATION AUTHORITY IN KINGDOM OF BAHRAIN

24 Apr 2018

BRIEF-Reshape Lifesciences Reports Qtrly Loss Per Share Of $0.45‍​

* RESHAPE LIFESCIENCES ANNOUNCES FOURTH QUARTER AND YEAR END 2017 FINANCIAL RESULTS

02 Apr 2018

BRIEF-Reshape Lifesciences Announces $6 Million Registered Direct Offering

* RESHAPE LIFESCIENCES ANNOUNCES $6 MILLION REGISTERED DIRECT OFFERING Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)

02 Apr 2018

BRIEF-Reshape Lifesciences Reschedules Fourth Quarter And Full Year 2017 Conference Call To April 2, 2018

* RESHAPE LIFESCIENCES ANNOUNCES UPDATE ON INTEGRATION EFFORTS AND RESCHEDULES FOURTH QUARTER AND FULL YEAR 2017 CONFERENCE CALL TO APRIL 2, 2018

20 Mar 2018

BRIEF-ReShape Lifesciences Agrees With Academy Medical To Provide Reshape Balloon To Department Of Defense Facilities

* RESHAPE LIFESCIENCES ANNOUNCES AGREEMENT WITH ACADEMY MEDICAL TO PROVIDE RESHAPE BALLOON AND RESHAPE VBLOC TO DEPARTMENT OF DEFENSE FACILITIES

07 Mar 2018

BRIEF-ReShape Lifesciences Q4 Preliminary Revenue About $795,000

* RESHAPE LIFESCIENCES REPORTS PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 REVENUE

01 Feb 2018

Earnings vs. Estimates